Single-Cell RNA-Seq Analysis Links DNMT3B and PFKFB4 Transcriptional Profiles with Metastatic Traits in Hepatoblastoma
Biomolecules · 2024
DOI: 10.3390/biom14111394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Christophe Desterke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Médecine du Kremlin Bicêtre, Université Paris-Sud, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Neoplasms, Phosphofructokinase-2, DNA Methyltransferase 3B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Filière Santé Maladie Rare du Foie de l’Adulte et de l’Enfant.
Abstract (Originalsprache)
Hepatoblastoma is the most common primary liver cancer in children. Poor outcomes are primarily associated with patients who have distant metastases. Using the Mammalian Metabolic Enzyme Database, we investigated the overexpression of metabolic enzymes in hepatoblastoma tumors compared to noncancerous liver tissue in the GSE131329 transcriptome dataset. For the overexpressed enzymes, we applied ElasticNet machine learning to assess their predictive value for metastasis. A metabolic expression score was then computed from the significant enzymes and integrated into a clinical-biological logistic regression model. Forty-one overexpressed enzymes distinguished hepatoblastoma tumors from noncancerous liver tissues. Eighteen of these enzymes predicted metastasis status with an AUC of 0.90, demonstrating 85.7% sensitivity and 92.3% specificity. ElasticNet machine learning identified DNMT3B and PFKFB4 as key predictors of metastasis. Univariate analyses confirmed the significance of these enzymes, with respective p-values of 0.0058 and 0.0091. A metabolic score based on DNMT3B and PFKFB4 expression discriminated metastasis status and high-risk CHIC scores (p-value = 0.005). The metabolic score was more sensitive than the C1/C2 classifier in predicting metastasis (accuracy: 0.72 vs. 0.55). In a regression model integrating the metabolic score with epidemiological parameters (gender, age at diagnosis, histological type, and clinical PRETEXT stage), the metabolic score was confirmed as an independent adverse predictor of metastasis (p-value = 0.003, odds ratio: 2.12). This study identified the dual overexpression of PFKFB4 and DNMT3B in hepatoblastoma patients at risk of metastasis (high-risk CHIC classification). The combined tumor expression of DNMT3B and PFKFB4 was used to compute a metabolic score, which was validated as an independent predictor of metastatic status in hepatoblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculté de Médecine du Kremlin Bicêtre, Université Paris-Sud, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.
- Cell and Tissue Biology Group, Anatomy and Cell Biology Department, University of Cantabria-IDIVAL, 39011 Santander, Spain
- International Joint Laboratory of Molecular Anthropological Oncology (LOAM), IRD, INEN, Lima 15038, Peru
ORCID-Profile: Raquel Francés, Claudia Monge, Pascal Pineau, Jorge Mata-Garrido
Förderung
- Filière Santé Maladie Rare du Foie de l’Adulte et de l’Enfant
Zitieren
APA
Desterke, C., Francés, R., Monge, C., Marchio, A., Pineau, P., & Mata-Garrido, J. (2024). Single-Cell RNA-Seq Analysis Links DNMT3B and PFKFB4 Transcriptional Profiles with Metastatic Traits in Hepatoblastoma. Biomolecules. https://doi.org/10.3390/biom14111394
Vancouver
Desterke C, Francés R, Monge C, Marchio A, Pineau P, Mata-Garrido J. Single-Cell RNA-Seq Analysis Links DNMT3B and PFKFB4 Transcriptional Profiles with Metastatic Traits in Hepatoblastoma. Biomolecules. 2024. doi:10.3390/biom14111394
BibTeX
@article{Desterke2024,
author = {Desterke, Christophe and Francés, Raquel and Monge, Claudia and Marchio, Agnès and Pineau, Pascal and Mata-Garrido, Jorge},
title = {Single-Cell RNA-Seq Analysis Links DNMT3B and PFKFB4 Transcriptional Profiles with Metastatic Traits in Hepatoblastoma},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14111394}
}
EUVIMED